| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/2011 | US20110082156 Fatty acid acipimox derivatives and their uses |
| 04/07/2011 | US20110082155 Novel 2-Pyridone Compounds |
| 04/07/2011 | US20110082154 Sigma ligands for neuronal regeneration and functional recovery |
| 04/07/2011 | US20110082153 Gamma secretase modulators |
| 04/07/2011 | US20110082152 Therapeutic agents useful for treating pain |
| 04/07/2011 | US20110082151 Sulfonylurea modulators of endothelin receptor |
| 04/07/2011 | US20110082150 Headache pre-emption by dihydroergotamine treatment during headache Precursor events |
| 04/07/2011 | US20110082149 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110082148 Treating, preventing or ameliorating a hyperproliferative disease/disorder |
| 04/07/2011 | US20110082147 Substituted imidazotriazines |
| 04/07/2011 | US20110082146 Compositions and methods for inhibition of the jak pathway |
| 04/07/2011 | US20110082145 Olopatadine compositions and uses thereof |
| 04/07/2011 | US20110082144 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 04/07/2011 | US20110082143 Bicyclic Heteroaryl Compounds |
| 04/07/2011 | US20110082142 Selective kinase inhibitors |
| 04/07/2011 | US20110082141 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 04/07/2011 | US20110082140 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and aids. |
| 04/07/2011 | US20110082139 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 04/07/2011 | US20110082138 Imidazopyridin-2-one derivatives |
| 04/07/2011 | US20110082137 New compounds for the treatment of cns disorders |
| 04/07/2011 | US20110082136 Inhibitors of janus kinases |
| 04/07/2011 | US20110082135 Inhibitors of akt activity |
| 04/07/2011 | US20110082134 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 04/07/2011 | US20110082133 Pyridone compounds |
| 04/07/2011 | US20110082132 [4-(1-amino-ehtyl) - cyclohexyl] -methyl-amine and [6-(1-amino-ehtyl) -tetrahydro-pyran-3-yl] -methyl-amine derivatives as antibacterials |
| 04/07/2011 | US20110082131 Triazole derivatives useful as axl inhibitors |
| 04/07/2011 | US20110082130 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 04/07/2011 | US20110082129 Organic compounds |
| 04/07/2011 | US20110082128 In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts |
| 04/07/2011 | US20110082127 New injectable formulations containing progesterone |
| 04/07/2011 | US20110082126 Method for treating inflammatory conditions |
| 04/07/2011 | US20110082125 Topical Ophthalmic or Otic Solution Formulations Containing Moxifloxacin Hydrocholoride and Dexamethasone Phosphate |
| 04/07/2011 | US20110082124 Detergent compositions for treatment of lipomas and other conditions |
| 04/07/2011 | US20110082123 6-Methylvitamin D3 Analogs and Their Uses |
| 04/07/2011 | US20110082122 19-Nor-Vitamin D Analogs With 1,2- or 3,2-Cyclopentene Ring |
| 04/07/2011 | US20110082121 1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses |
| 04/07/2011 | US20110082120 Substituted thioacetic acid salicylate derivatives and their uses |
| 04/07/2011 | US20110082119 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 04/07/2011 | US20110082118 Onychomycosis Treatment Delivery System |
| 04/07/2011 | US20110082117 Phenyl sulfonamides as modulators of ion channels |
| 04/07/2011 | US20110082116 Novel compounds as cannabinoid receptor ligands |
| 04/07/2011 | US20110082115 Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen |
| 04/07/2011 | US20110082114 Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors |
| 04/07/2011 | US20110082113 Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity |
| 04/07/2011 | US20110082112 Antiviral phosphinate compounds |
| 04/07/2011 | US20110082111 Polo-like kinase inhibitors |
| 04/07/2011 | US20110082110 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 04/07/2011 | US20110082109 Novel acyl guanidine derivatives |
| 04/07/2011 | US20110082108 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes |
| 04/07/2011 | US20110082107 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 04/07/2011 | US20110082106 Methods of activating nkt cells |
| 04/07/2011 | US20110082105 Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof |
| 04/07/2011 | US20110082104 Alkylated semi synthetic glycosaminoglycosan ethers, and methods for making and using thereof |
| 04/07/2011 | US20110082103 Anoectochilus SPP. polysaccharide extracts for stimulating growth of advantageous bacteria, stimuating release of granulocyte colony-Stimulating factor, modulating T helper cell type I, and/or modulating T helper cell type II and uses of the same |
| 04/07/2011 | US20110082102 Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation |
| 04/07/2011 | US20110082101 Combinations comprising epothilones and anti-metabolites |
| 04/07/2011 | US20110082100 Therapeutic substances that modulate genome methylation |
| 04/07/2011 | US20110082099 Methods and Compositions for the Treatment of Cystic Fibrosis and Related Illnesses |
| 04/07/2011 | US20110082098 Novobiocin analogues and treatment of polycystic kidney disease |
| 04/07/2011 | US20110082097 Amino acid composition for improving glucose tolerance |
| 04/07/2011 | US20110082096 Gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases |
| 04/07/2011 | US20110082091 Method for Preclinical Testing of Immunomodulatory Drugs |
| 04/07/2011 | US20110082090 Compounds suited as nanocarriers for active agents and their use |
| 04/07/2011 | US20110082086 Medicament for use in connection with cartilage impairment |
| 04/07/2011 | US20110082077 Sialic acid derivatives for protein derivatisation and conjugation |
| 04/07/2011 | US20110082076 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 04/07/2011 | US20110082071 Delivery system for an active ingredient |
| 04/07/2011 | US20110082070 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 04/07/2011 | US20110081657 Controlled platelet activation to monitor therapy of adp antagonists |
| 04/07/2011 | US20110081429 Composition for external use |
| 04/07/2011 | US20110081428 Use of thioflavin-like compounds to increase life span and/or health span |
| 04/07/2011 | US20110081427 Nitroxyl Progenitors in the Treatment of Heart Failure |
| 04/07/2011 | US20110081426 Aminothiazole modulators of beta-3-adrenoreceptor |
| 04/07/2011 | US20110081423 Tissue Stabilization for Heart Failure |
| 04/07/2011 | US20110081422 Prolonged release of local anesthetics using microparticles and surgery applications |
| 04/07/2011 | US20110081420 Method of forming prolonged-release injectable steroids |
| 04/07/2011 | US20110081419 Ion exchange resin treated to control swelling |
| 04/07/2011 | US20110081418 Transdermal absorption enhancer |
| 04/07/2011 | US20110081417 Surgical compositions |
| 04/07/2011 | US20110081413 Pharmaceutical Compositions Comprising Phosphate-Binding Polymer |
| 04/07/2011 | US20110081412 Orally disintegrable tablets |
| 04/07/2011 | US20110081411 Orally Administered Corticosteroid Compositions |
| 04/07/2011 | US20110081410 Therapeutic agent for local inflammation |
| 04/07/2011 | US20110081409 Selective inhibitors of histone deacetylase |
| 04/07/2011 | US20110081404 Novel liposome compositions |
| 04/07/2011 | US20110081401 Dermal patch comprising chondrus crispus extract |
| 04/07/2011 | US20110081393 Cooling sensation agent composition, sensory stimulation agent composition and use of the same |
| 04/07/2011 | US20110081387 Liposomes encapsulating an oxazolidin-2-one compound |
| 04/07/2011 | US20110081385 Compositions and Methods for Sleep Regulation |
| 04/07/2011 | US20110081374 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
| 04/07/2011 | US20110081365 Compounds and compositions as tlr activity modulators |
| 04/07/2011 | US20110081364 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 04/07/2011 | US20110081362 Treatment of cancer |
| 04/07/2011 | US20110081359 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 04/07/2011 | US20110081352 Immunogenic peptides and methods of use for treating and preventing cancer |
| 04/07/2011 | US20110081348 Fungal signalling and metabolic enzymes |
| 04/07/2011 | US20110081341 Immunopotentiative composition |
| 04/07/2011 | US20110081338 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110081337 Function of gpr4 in vascular inflammatory response to acidosis and related methods |